Grabowska, Anna D, Lacerda, Eliana M, Nacul, Luís et al. · Frontiers in pediatrics · 2020 · DOI
This study reviews how genetic research teams check the quality of their data when looking for genes connected to ME/CFS. The researchers examined the methods different studies use to make sure their genetic findings are reliable and trustworthy. Understanding these quality control checks helps ensure that genetic discoveries about ME/CFS are real and not due to errors in the data.
Ensuring consistent, rigorous quality control in genetic studies is fundamental to identifying true genetic factors contributing to ME/CFS susceptibility. Poor QC procedures can lead to false genetic associations that waste research resources and mislead the field. This review helps establish best practices that will improve future ME/CFS genetic research and increase confidence in findings.
This study does not identify specific genes or genetic variants responsible for ME/CFS—it only reviews the methods used to find them. It does not prove that any particular QC approach is superior to others, nor does it demonstrate the biological mechanism by which genetic factors might contribute to disease. The review cannot establish causation between genes and ME/CFS susceptibility.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →